A federal appeals court upholds the dismissal on preemption grounds of a personal injury lawsuit filed over the alleged off-label use of Medtronic's controversial InFuse bone-growth protein.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1DAWUTv
Cap comentari:
Publica un comentari a l'entrada